Arkolith/Insider Trading/EIKN/Form 4

Foresite Capital Opportunity Management V, LLC

10% OwnerEikon Therapeutics, Inc. (EIKN) · full profile →Form 4 · filed Feb 6, 2026
Net Buying
Open-Market Buys
$1000K
Open-Market Sells
$0
Net Open-Market Flow
$1000K
Transactions
29
15 non-derivative · 14 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Conversion(C)1.3M—$01.3M
Feb 4, 2026Buy(P)56K$18.00$1000K1.3M
Feb 4, 2026Conversion(C)38K—$01.7M
Feb 4, 2026Conversion(C)229K—$01.9M
Feb 4, 2026Conversion(C)698K—$0698K
Feb 4, 2026Conversion(C)38K—$0736K
Feb 4, 2026Conversion(C)2K—$0737K
Feb 4, 2026Conversion(C)67K—$0805K
Feb 4, 2026Conversion(C)459K—$01.3M
Feb 4, 2026Conversion(C)349K—$0349K
Feb 4, 2026Conversion(C)38K—$0387K
Feb 4, 2026Conversion(C)922—$0388K
Feb 4, 2026Conversion(C)38K—$0426K
Feb 4, 2026Conversion(C)409K—$0409K
Feb 4, 2026Conversion(C)336K—$01.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 4, 2026Conversion(C)3.0M—$00
Feb 4, 2026Conversion(C)12K—$00
Feb 4, 2026Conversion(C)7K—$00
Feb 4, 2026Conversion(C)501K—$00
Feb 4, 2026Conversion(C)284K—$00
Feb 4, 2026Conversion(C)1.7M—$00
Feb 4, 2026Conversion(C)3.4M—$00
Feb 4, 2026Conversion(C)282K—$00
Feb 4, 2026Conversion(C)282K—$00
Feb 4, 2026Conversion(C)282K—$00
Feb 4, 2026Conversion(C)2.6M—$00
Feb 4, 2026Conversion(C)5.2M—$00
Feb 4, 2026Conversion(C)10.0M—$00
Feb 4, 2026Conversion(C)2.5M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-011662) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML